Loading...

Louis M Kwong

Title(s)Professor of Clinical , Orthopaedic Surgery
SchoolMedicine
Address760 Westwood Plaza 76-143
Los Angeles CA 90024
Phone(310) 222-2716
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Current illicit drug use profile of orthopaedic trauma patients and its effect on hospital length of stay. Injury. 2020 Apr; 51(4):887-891. Shymon SJ, Arthur D, Keeling P, Rashidi S, Kwong LM, Andrawis JP. PMID: 32145902.
      View in: PubMed   Mentions:    Fields:    
    2. A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban. Curr Med Res Opin. 2017 09; 33(9):1717-1723. Kwong LM, Turpie AGG, Tamayo S, Peacock WF, Yuan Z, Sicignano N, Hopf KP, Patel MR. PMID: 28678604.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Postorthopedic Surgery Joint Replacement Surgery Venous Thromboembolism Prophylaxis. Hematol Oncol Clin North Am. 2016 10; 30(5):1007-18. Kwong LM, Kimball JA. PMID: 27637304.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Real-world data confirm clinical trial outcomes for rivaroxaban in orthopaedic patients. Curr Orthop Pract. 2015 May; 26(3):299-305. Kwong L, Turpie AG. PMID: 25973138.
      View in: PubMed   Mentions:
    5. Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban. Clin Pharmacol. 2013; 5:143-8. Kwong LM. PMID: 23946671.
      View in: PubMed   Mentions:
    6. Rivaroxaban, an oral, direct factor Xa inhibitor: a new option for thromboprophylaxis. Orthopedics. 2012 Nov; 35(11):919; discussion 919. Kwong LM. PMID: 23127435.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Drug interactions with rivaroxaban following total joint replacement surgery. Ann Pharmacother. 2012 Sep; 46(9):1232-8. Kwong LM, Tong LM. PMID: 22932305.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    8. Rivaroxaban, an oral, direct factor Xa inhibitor: a new option for thromboprophylaxis. Orthopedics. 2012 Jun; 35(6):e932-8;discussion e939. Kwong LM. PMID: 22691670.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a U.S. payer's perspective. Pharmacoeconomics. 2012 Feb 01; 30(2):87-101. Duran A, Sengupta N, Diamantopoulos A, Forster F, Kwong L, Lees M. PMID: 22187932.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    10. Thromboprophylaxis, bleeding and post-operative prosthetic joint infection in total hip and knee arthroplasty: a comprehensive literature review. Expert Opin Pharmacother. 2012 Feb; 13(3):333-44. Kwong LM, Kistler KD, Mills R, Wildgoose P, Klaskala W. PMID: 22220855.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    11. Prevention of venous thromboembolism after hip or knee arthroplasty: findings from a 2008 survey of US orthopedic surgeons. J Arthroplasty. 2012 May; 27(5):659-66.e5. Anderson FA, Huang W, Friedman RJ, Kwong LM, Lieberman JR, Pellegrini VD. PMID: 22035977.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    12. Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer's perspective. J Med Econ. 2011; 14(6):824-34. Duran A, Sengupta N, Diamantopoulos A, Forster F, Kwong L, Lees M. PMID: 22023098.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    13. Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data. Vasc Health Risk Manag. 2011; 7:461-6. Kwong LM. PMID: 21822393.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty. Am J Manag Care. 2011 Feb; 17(1 Suppl):S22-6. Kwong LM. PMID: 21517652.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    15. Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery. Curr Med Res Opin. 2011 Feb; 27(2):423-9. Baser O, Supina D, Sengupta N, Wang L, Kwong L. PMID: 21192759.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    16. Never events and related quality measures following total hip and total knee replacement. Orthopedics. 2010 Nov; 33(11):838. Kwong LM. PMID: 21155137.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Analysis of venous thromboprophylaxis duration and outcomes in orthopedic patients. Am J Manag Care. 2010 Nov; 16(11):857-63. Wells PS, Borah BJ, Sengupta N, Supina D, McDonald HP, Kwong LM. PMID: 21348557.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    18. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery. Am J Health Syst Pharm. 2010 Sep 01; 67(17):1438-45. Baser O, Supina D, Sengupta N, Wang L, Kwong L. PMID: 20720243.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    19. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet. 2009 May 16; 373(9676):1673-80. Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD. PMID: 19411100.
      View in: PubMed   Mentions: 173     Fields:    Translation:HumansCTClinical Trials
    20. Decreased venous thromboembolism with injectable vs oral anticoagulation after discharge for major orthopedic surgery. J Arthroplasty. 2008 Sep; 23(6 Suppl 1):25-30. Kwong LM, Happe LE, Horblyuk R, Farrelly E. PMID: 18722300.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery. Clin Pharmacokinet. 2008; 47(3):203-16. Mueck W, Eriksson BI, Bauer KA, Borris L, Dahl OE, Fisher WD, Gent M, Haas S, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AG. PMID: 18307374.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCTClinical Trials
    22. Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies. Thromb Haemost. 2007 Jun; 97(6):931-7. Fisher WD, Eriksson BI, Bauer KA, Borris L, Dahl OE, Gent M, Haas S, Homering M, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AG. PMID: 17549294.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    23. Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis. Thromb Res. 2007; 121(1):17-24. Shorr AF, Kwong LM, Sarnes M, Happe L, Farrelly E, Mody-Patel N. PMID: 17449088.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery. Value Health. 2006 Mar-Apr; 9(2):68-76. Sullivan SD, Kwong L, Nutescu E. PMID: 16626410.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    25. Deep vein thrombosis prophylaxis: better living through chemistry--in the affirmative. J Arthroplasty. 2005 Jun; 20(4 Suppl 2):12-4. Kwong LM. PMID: 15991121.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Hip fracture and venous thromboembolism in the elderly. J Surg Orthop Adv. 2004; 13(3):139-48. Kwong LM. PMID: 15559689.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Balancing new technology with established techniques. Orthopedics. 2003 Aug; 26(8 Suppl):s873-4. Kwong LM. PMID: 12934743.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. A modular distal fixation option for proximal bone loss in revision total hip arthroplasty: a 2- to 6-year follow-up study. J Arthroplasty. 2003 Apr; 18(3 Suppl 1):94-7. Kwong LM, Miller AJ, Lubinus P. PMID: 12730939.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    29. Selective factor Xa inhibitors: practical guidelines for use. Am J Orthop (Belle Mead NJ). 2002 Nov; 31(11 Suppl):3. Kwong LM. PMID: 12463576.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Thromboprophylaxis dosing: the relationship between timing of first administration, efficacy, and safety. Am J Orthop (Belle Mead NJ). 2002 Nov; 31(11 Suppl):16-20. Kwong LM, Muntz JE. PMID: 12463579.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans